Cargando…
Saracura-Mirá, a Proposed Brazilian Amazonian Adaptogen from Ampelozizyphus amazonicus
The Amazon Forest is known all over the world for its diversity and exuberance, and for sheltering several indigenous groups and other traditional communities. There, as well as in several other countries, in traditional medical systems, weakness, fatigue and debility are seen as limiting health con...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781190/ https://www.ncbi.nlm.nih.gov/pubmed/35050079 http://dx.doi.org/10.3390/plants11020191 |
_version_ | 1784638030436368384 |
---|---|
author | Leitão, Suzana Guimarães Leitão, Gilda Guimarães de Oliveira, Danilo Ribeiro |
author_facet | Leitão, Suzana Guimarães Leitão, Gilda Guimarães de Oliveira, Danilo Ribeiro |
author_sort | Leitão, Suzana Guimarães |
collection | PubMed |
description | The Amazon Forest is known all over the world for its diversity and exuberance, and for sheltering several indigenous groups and other traditional communities. There, as well as in several other countries, in traditional medical systems, weakness, fatigue and debility are seen as limiting health conditions where medicinal plants are often used in a non-specific way to improve body functions. This review brings together literature data on Ampelozizyphus amazonicus, commonly known in Brazil as “saracura-mirá” and/or “cerveja de índio”, as an Amazonian adaptogen, including some contributions from the authors based on their ethnographic and laboratory experiences. Topics such as botany, chemistry, ethnopharmacological and pharmacological aspects that support the adaptogen character of this plant, as well as cultivation, market status and supply chain aspects are discussed, and the gaps to establish “saracura-mirá” as an ingredient for the pharmaceutical purposes identified. The revised data presented good scientific evidence supporting the use of this Amazonian plant as a new adaptogen. Literature data also reveal that a detailed survey on natural populations of this plant is needed, as well as agronomical studies that could furnish A. amazonicus bark as a raw material. Another important issue is the lack of developed quality control methods to assure its quality assessment. |
format | Online Article Text |
id | pubmed-8781190 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87811902022-01-22 Saracura-Mirá, a Proposed Brazilian Amazonian Adaptogen from Ampelozizyphus amazonicus Leitão, Suzana Guimarães Leitão, Gilda Guimarães de Oliveira, Danilo Ribeiro Plants (Basel) Review The Amazon Forest is known all over the world for its diversity and exuberance, and for sheltering several indigenous groups and other traditional communities. There, as well as in several other countries, in traditional medical systems, weakness, fatigue and debility are seen as limiting health conditions where medicinal plants are often used in a non-specific way to improve body functions. This review brings together literature data on Ampelozizyphus amazonicus, commonly known in Brazil as “saracura-mirá” and/or “cerveja de índio”, as an Amazonian adaptogen, including some contributions from the authors based on their ethnographic and laboratory experiences. Topics such as botany, chemistry, ethnopharmacological and pharmacological aspects that support the adaptogen character of this plant, as well as cultivation, market status and supply chain aspects are discussed, and the gaps to establish “saracura-mirá” as an ingredient for the pharmaceutical purposes identified. The revised data presented good scientific evidence supporting the use of this Amazonian plant as a new adaptogen. Literature data also reveal that a detailed survey on natural populations of this plant is needed, as well as agronomical studies that could furnish A. amazonicus bark as a raw material. Another important issue is the lack of developed quality control methods to assure its quality assessment. MDPI 2022-01-12 /pmc/articles/PMC8781190/ /pubmed/35050079 http://dx.doi.org/10.3390/plants11020191 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Leitão, Suzana Guimarães Leitão, Gilda Guimarães de Oliveira, Danilo Ribeiro Saracura-Mirá, a Proposed Brazilian Amazonian Adaptogen from Ampelozizyphus amazonicus |
title | Saracura-Mirá, a Proposed Brazilian Amazonian Adaptogen from Ampelozizyphus amazonicus |
title_full | Saracura-Mirá, a Proposed Brazilian Amazonian Adaptogen from Ampelozizyphus amazonicus |
title_fullStr | Saracura-Mirá, a Proposed Brazilian Amazonian Adaptogen from Ampelozizyphus amazonicus |
title_full_unstemmed | Saracura-Mirá, a Proposed Brazilian Amazonian Adaptogen from Ampelozizyphus amazonicus |
title_short | Saracura-Mirá, a Proposed Brazilian Amazonian Adaptogen from Ampelozizyphus amazonicus |
title_sort | saracura-mirá, a proposed brazilian amazonian adaptogen from ampelozizyphus amazonicus |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781190/ https://www.ncbi.nlm.nih.gov/pubmed/35050079 http://dx.doi.org/10.3390/plants11020191 |
work_keys_str_mv | AT leitaosuzanaguimaraes saracuramiraaproposedbrazilianamazonianadaptogenfromampelozizyphusamazonicus AT leitaogildaguimaraes saracuramiraaproposedbrazilianamazonianadaptogenfromampelozizyphusamazonicus AT deoliveiradaniloribeiro saracuramiraaproposedbrazilianamazonianadaptogenfromampelozizyphusamazonicus |